Monitoring of Autoantibodies Following Autologous Hematopoietic Stem Cell Transplantation in 6 Children with Recently Diagnosed Type 1 Diabetes Mellitus
CONCLUSIONS Autologous hematopoietic stem cell transplantation without immunoablation was safe and effective in significantly decreasing the production and effect of autoantibodies against ICA, GAD, and IA2, as well as decreasing blood sugar levels and HbA1c.PMID:36659834 | DOI:10.12659/MSM.938979
Source: Medical Science Monitor - Category: Research Authors: Alejandro D Mesples Desiree C T Cox Harriet D Lundy Sheena Antonio-Collie Charles W Diggiss Jonathan R T Lakey Source Type: research
More News: Autoimmune Disease | Biomedical Science | Children | Diabetes | Diabetes Mellitus | Diabetes Type 1 | Endocrinology | Filgrastim | Insulin | Neulasta | Neupogen | Research | Science | Stem Cell Therapy | Stem Cells | Study | Sugar | Transplants